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Objective: The purpose of this study was to use microarray technology to: (1) understand the early
molecular events underlying the damage of articular cartilage initiated by this surgical procedure, and (2)
determine whether these changes mimic those that are occurring in human osteoarthritic (OA) cartilage.
Design: Cartilage was harvested from both medial and lateral sides of the tibial plateaus and femoral
condyles of both meniscal tear (MT) and sham surgery groups on days 3, 7 and 21 post-surgery. mRNA
prepared from these rat cartilage samples was used for microarray analysis.
Results: Statistical analysis identiﬁed 475 genes that were differentially expressed between the sham and
MT groups, at one or more of the time points that were analyzed. By integrating these genes with OA-
related genes reported previously in a rat OA model and in human OA array studies, we identiﬁed 20
commonly changed genes. Six out of these 20 genes (Col5A1, Col6A2, INHBA, LTBP2, NBL1 and SERPINA1)
were differentially expressed in two animal models and in human OA. Pathway analysis identiﬁed some
key features of OA pathology, namely cartilage extracellular matrix remodeling, angiogenesis, and
chondrocyte cell death that were recapitulated in the animal models. The rat models suggested increased
inﬂammation and cholesterol metabolic pathways may play important role in early cartilage
degeneration.
Conclusion:We identiﬁed a large number of differentially expressed genes in the articular cartilage of the
MT model. While there was lack of overall identity in cartilage gene expression between the rat models
and human OA, several key biological processes were recapitulated in the rat MT OA model.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is one of the most frequent symptomatic
health problems for middle aged and older people1. The pathology
of OA-related joint degeneration is characterized by progressive
loss of articular cartilage, apoptosis of chondrocytes and activationo: J.E. Onyia, Lilly Research
46285, USA. Tel: 1-317-277-
: P.G. Mitchell, Lilly Research
46285, USA. Tel: 1-317-651-
llpg@lilly.com (P.G. Mitchell).
s Research Society International. Pof repair mechanisms. In addition, osteophytes form at the joint
margin and subchondral bone undergoes remodeling and sclerosis.
The main risk factors for OA are age, obesity and joint trauma;
however, the molecular pathophysiological pathways in OA and
relationships to clinical manifestations of OA, are complex and
poorly understood2. Many local mechanical factors contribute to
development of OA, among which is integrity and function of the
meniscus3. The knee meniscus bears mechanical loading, absorbs
shock, and contributes to joint lubrication4. Patients who have
undergone total or partial meniscectomies are at high risk of
developing subsequent knee OA5, which may be due to the higher
focal stress imposed on articular cartilage and subchondral bone
after meniscal surgery. The strong association between meniscal
damage and cartilage loss has made the rat meniscal tear (MT)
model an attractive preclinical model for degenerative jointublished by Elsevier Ltd. All rights reserved.
Table I
DE genes at 3, 7 and 21 days after disease induction
Gene Description Fold change
3 days 7 days 21 days
Ccl2 Ccl2: small inducible cytokine A2, mediates
monocyte recruitment in inﬂammation
5.7 2.7 2.3
Chi3l1 Chi3l1: protein with strong similarity to
chitinase 3-like 1 (cartilage glycoprotein-
39, human CHI3L1), which binds chitin but
does not have chitinase activity, contains
a glycosyl hydrolase family 18 domain
2.4 2.9 2.8
Cktsf1b1 Cktsf1b1: cysteine knot superfamily 1 BMP
antagonist 1 (gremlin), antagonizes bone
morphogenetic protein signaling and
inhibits cell proliferation, plays a role in
development; downregulation of human
CKTSF1B1 is associated with tumor
progression
1.7 1.9 1.6
Crlf1 Crlf1: cytokine receptor-like factor 1,
secreted cytokine type 1 receptor, forms
a ciliary neurotrophic factor receptor (Cntfr)
ligand with cardiotrophin-like cytokine
(Bsf3)
1.8 1.7 2.3
Egﬂ6 Egﬂ6: EGF-like-domain multiple 6,
epidermal growth factor (EGF) repeat
superfamily member, contains ﬁve EGF
repeats and a meprin/A5-protein/PTPmu
(MAM) domain, may play a role in
developmental disorders
1.8 1.5 1.7
Lbp Lbp: lipopolysaccharide (LPS)-binding
protein, acute phase protein with
bactericidal activity, binds to lipid A moiety
of bacterial LPS and disperses LPS
aggregates, mediates proinﬂammatory
effects of LPS, plasma level of human LBP
elevated in cancer
2.7 2.3 2.5
Lgl1 Lgl1: late gestation lung protein 1,
a member of the CRISP family of cysteine-
rich extracellular proteins, plays a role in
airway branching morphogenesis during
fetal development
3.4 2.1 2.5
Ptgs2 Ptgs2: prostaglandin endoperoxide
synthase 2, converts arachidonate to
inﬂammatory prostaglandins; mutation of
the mouse Ptgs2 gene causes nephropathy
and reproductive failure; inhibition of
human PTGS2 may be therapeutic for RA
3.6 1.8 1.8
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changes induced by this surgery and how these changes may relate
to the human disease.
DNA microarray technology allows for simultaneous interroga-
tion of tens of thousands of genes9. Data integration can lead to
a better understanding of pathogenic mechanisms, as well as
identiﬁcation of new diagnostic markers and cellular targets for
therapeutic intervention. Array technology has been applied in
studies of cartilage from patients with both rheumatoid arthritis
(RA) and OA patients10e12. The latest application of DNAmicroarray
technology in arthritis resulted in identiﬁcation of hundreds of
novel RA-related genes13, characterization of OA-related genes11,
and identiﬁcation of clock as a novel mechanosensitive gene down-
regulated in osteoarthritic cartilage14. The purpose of our studywas
to use DNA microarray to: (1) identify early molecular events
underlying the damage to articular cartilage in the rat MT model,
and (2) determine whether these changes model those that are
occurring in human osteoarthritic cartilage.
Methods
Induction of OA
OA was surgically induced as described previously6. Brieﬂy, on
day 0, 75 male Lewis rats (z300 g) were subjected to medial MT
surgery while a further 75 animals underwent sham surgery. On
days 3, 7 and 21, cartilage was harvested from the MT or sham
operated knees from both the medial and lateral sides of tibial
plateaus and femoral condyles of 25 rats from each of the groups
and snap frozen in liquid nitrogen until RNA isolation. Cartilage
from each of ﬁve animals was pooled creating a total of ﬁve
potential samples from each condition (MT or sham) at each time
point.
Total RNA was isolated using Trizol (Invitrogen, Carlsbad, CA)
as recommended by the manufacturer and further puriﬁed using
RNeasy spin columns (Qiagen, Valencia, CA). RNAwas quantiﬁed by
measuring the absorbance at 260 nm and the quality of the RNA
samples was assessed by agarose gel electrophoresis for the
integrity of 18S and 28S ribosomal RNA bands and also by the 260/
280 nm absorbance ratio. RNA was prepared from each of the
pooled MT and sham samples, and used to proﬁle gene expression
as a function of time via DNA microarray.Fig. 1. Venn diagram of the number of DE genes identiﬁed in the articular cartilage of
MT rat model at 3, 7 and 21 days post-MT. The numbers in the parenthesis indicate the
number of DE genes identiﬁed at three different time points post-surgery in the MT
model, while the numbers in the overlapping areas show the number of commonly
regulated genes between the three time points.
Ptn Ptn: pleiotrophin, a heparin binding protein
that has a role in neurogenesis, cell
proliferation, and differentiation
2.3 1.5 1.7
Sectm1 Sectm1: protein with high similarity to
secreted and transmembrane 1 (mouse
Sectm1), which has cell growth-inhibitory
properties and may play a role in
hematopoiesis and immune processes
3.9 2.1 1.6
Serpine1 Serpine1: serine (or cysteine)
proteinase inhibitor clade E member 1
(plasminogen activator inhibitor 1), inhibits
ﬁbrinolysis; altered human SERPINE1
expression may be therapeutic for type II
diabetes, glioma, melanoma, and breast and
lung cancer
2.8 2.4 2.9Affymetrix microarray study
RNA labeling was performed using The Onyx system from
MWG-Biotech and Aviso using the standard labeling protocol.
Biotin labeled cRNA was fragmented and hybridized to the Affy-
metrix rat Genome 230 2.0 DNA chips. Chip processing, imagine
capturing, and raw data analysis were performed using the Affy-
metrix Microarray Suite MAS5.
Fig. 2. The number of DE genes commonly identiﬁed in the two surgically induced OA
rat models (MT and ACLT). Numbers in the parenthesis indicate the number of DE
genes identiﬁed at different time points in the MT and ACLT models. Numbers in the
overlapping areas show the number of commonly regulated genes, with percentages of
identities shown in the parenthesis, at 4 weeks in the ACLT and at 3, 7 or 21 days
respectively in the MT model. Overlapping genes with fold changes at each time point
can be found in the Supplement Table S2.
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Quantitative real-time polymerase chain reaction (PCR) was
performed using ABI Prism Sequence Detection System 5700
(Applied Biosystems, Foster City, CA). RNA samples were treated
with DNaseI for 30 min at 37C, using a DNA-free kit (Ambion,
Austin, TX). First strand cDNA was synthesized from approxi-
mately 0.5 mg of total RNA with random hexamer primers using
the SUPERSCRIPT III ﬁrst strand synthesis kit (Invitrogen, Carls-
bad, CA). Fluorogenic primer/probe sets for target genes
(collagen 5a, Rn01435869_m1; collagen 6a, Rn01429506_m1)
were purchased from Applied Biosystems as Assays on Demand
reagents (Foster City, CA). Speciﬁc ampliﬁcation reactions from
the cDNAs were carried out by 2-step real-time PCR and the
relative quantities were obtained by generating a standard curve
for each gene. The expression levels of genes were normalized to
18S ribosomal RNA used as internal control. All measurements
were performed on triplicate samples. Results of real-time PCR
were analyzed by Student’s t test and probability (P) values
<0.05 were considered statistically signiﬁcant.
Identiﬁcation of differentially expressed (DE) genes
To identify DE genes, an analysis of variance (ANOVA) model
was ﬁtted on each of the probe sets on the chip. The intensity value,
Affymetrix MAS5 signal, of a particular gene was modeled asTable II
Gene Ontology terms enriched with DE genes commonly identiﬁed in MT and ACLT
OA models
GO term Gene # P-value
Extracellular region 31 0.0000
Extracellular space 25 0.0000
ECM 10 0.0000
Cell development 15 0.0001
Regulation of cell proliferation 8 0.0035
Regulation of apoptosis 8 0.0043
Organ morphogenesis 7 0.0055
Inﬂammatory response 6 0.0069
Nervous system development 9 0.0097
Cell morphogenesis 7 0.0100
Cellular structure morphogenesis 7 0.0100
Tissue development 6 0.0129
Skeletal development 5 0.0152
Cell surface 4 0.0296
Vasculature development 4 0.0357yki ¼ mk þ 3ki
where yki is the signal of the ith animal in treatment group k, mk is
the group mean of treatment k, and 3ki is the measurement error
(chip-to-chip variations plus animal-to-animal variations) assumed
to follow normal distribution N(0, s). Since thousands of hypoth-
eses were tested simultaneously, the issue of multiplicity is a big
concern. To control the false positive rate, a False Discovery Rate
(FDR) was used to adjust the P-values. Genes were called differ-
entially expressed or DE whose probe(s) passed all three inde-
pendent tests, namely, minimum expression, FDR and fold change.
First, we only considered genes which were either expressed or
induced byMTsurgery in cartilage. Thus, we excluded probes called
“Absent” in more than half of all chips in the study and required
a minimum of 500 average expression signal in at least one of the
comparison groups. Secondly, genes with one or more probes
whose FDR was less than 0.1 and P-value less than 0.05 were
considered statistically signiﬁcant. An arbitrary cutoff of absolute
fold change larger than 1.5 was applied.
Literature mining and pathway analysis
OA-related genes were identiﬁed from NCBI PubMed by using
NCBI Entez tools. Enrichment test of changed genes for biological
processes and pathways was performed by using DAVID system15
with Affymetrix rat DNA chip RGU230 2.0 as the background
gene list. P-value was calculated by DAVID using Fisher’s exact test.
Biological processes with estimated P-value<0.05 were considered
as signiﬁcantly enriched, suggesting functional relevancy to disease
progression.
Identiﬁcation of commonly changed genes in the cartilage of human
OA and OA rat models
Aigner et al.11 proﬁled the transcriptome of human OA cartilage.
A total of 223 genes, and their fold changes, were retrieved from the
supporting material in the paper, which were then mapped to rat
orthologous genes using NCBI HomoloGene database16. Appleton
et al.12 characterized a different surgically induced rat OA model,
namely anterior cruciate ligament transection (ACLT). The authors
proﬁled the transcriptome of the articular cartilage of the ACLT
model. Their original data was downloaded from the NCBI GEO
database16 and the same statistical analysis applied as described
above. The commonly changed genes were identiﬁed by comparing
the two lists of genes with the genes identiﬁed from the rat MT OA
model.
Results
Identiﬁcation and comparison of DE genes in the MT, ACLT and
human OA articular cartilage
A total of 475 genes expressed in the articular cartilage were
found to be signiﬁcantly changed in response to MT at one or more
time points when compared with the time-matched sham control
group. The numbers of DE genes at 3, 7 and 21 days after disease
induction were 337, 79 and 112 respectively. Thus, the number of
DE genes at 3 days was much larger than at later time points. A
Venn diagram of the DE genes (Fig.1) indicates that there were only
11 genes differentially expressed at all three time points (Table I).
The complete list of all 475 DE genes can be accessed in
Supplemental Table S1.
Appleton et al. proﬁled transcriptional changes of the articular
cartilage of the ACLT model. By applying the same statistical
T. Wei et al. / Osteoarthritis and Cartilage 18 (2010) 992e1000 995analysis to their dataset, we identiﬁed 649 DE genes in response to
the disease induction. These DE genes were then compared with
the 475 DE genes identiﬁed in the MT model, resulting in 61 genes
that were commonly regulated in MT and ACLT models (Fig. 2).
Supplementary Table S2 lists all 61 genes with their fold changes.
Pathway analysis of the 61 genes revealed common biological
processes implicated in the pathological development (Table II).
The most abundant changes were in pathways related to the
extracellular matrix (ECM).
By searching PubMed we identiﬁed 175 known OA-related
genes, 19 of which were among the 475 rat genes identiﬁed in the
MT model (Table III). Genes reported to be up-regulated in OA
cartilage such as Adamts417, MMP318, MMP1419, Chi3l120, Ptgs221,
were also up-regulated in the MT model (Table III).
Aigner et al.11 identiﬁed 223 DE genes from the articular carti-
lage of human OA patients. We compared them with the DE genes
identiﬁed from the MT and ACLT models through orthologous
mapping. As shown in Table IV, there are 20 DE genes identiﬁed in
OA and in at least one of the OA models. Six genes (namely Col5A1,
Col6A2, INHBA, LTBP2, NBL1 and SERPINA1) were commonly
changed in the same direction in the MT and ACLT models and in
human OA. Real-time PCR conﬁrmed up-regulation of two selected
genes Col5A1 and Col6A2 in the rat MT model (Fig. 3).Table III
Known OA-related genes with altered expression in the MT model
Gene Description
Adamts4 Adamts4: a disintegrin-like and metalloprotease with thrombospondin ty
regulates collagen ﬁbril diameter in development.
Atp7a Atp7a: copper transporting ATPase alpha polypeptide, a copper transporti
ATPase that is involved in copper homeostasis.
Bmp2 Bmp2: bone morphogenetic protein 2, member of the transforming growt
factors that signal through receptor serineethreonine kinases.
Chi3l1 Chi3l1: protein with strong similarity to chitinase 3-like 1 (cartilage glyco
human CHI3L1), which binds chitin but does not have chitinase activity, c
glycosyl hydrolase family 18 domain.
Col1a1 Col1a1: collagen type I alpha 1.
Col3a1 Col3a1: collagen type III alpha 1.
Enpp1 Enpp1: ectonucleotide pyrophosphataseephosphodiesterase 1 (plasma ce
surface tumor and neural differentiation antigen that may inhibit insulin
receptor tyrosine kinases.
Inhba Inhba: inhibin beta A, a homodimeric subunit of activin A, may be involve
development and wound healing.
Mapk14 Mapk14: mitogen activated protein kinase 14, serineethreonine protein k
acts in signaling in response to cytokines and physiological stimuli, may t
apoptosis in response to stress.
Mmp14 Mmp14: matrix metalloproteinase 14, activates the collagenase gelatinase
plays a role in ECM remodeling.
Mmp3 Mmp3: matrix metalloproteinase 3 (stromelysin 1), a putative matrix met
that may be involved in the regulation of epithelial differentiation.
Ptgs2 Ptgs2: prostaglandin endoperoxide synthase 2, converts arachidonate to i
prostaglandins.
Serpina1 Serpina1: alpha 1-protease inhibitor (alpha 1-antitrypsin).
Serpine1 Serpine1: serine (or cysteine) proteinase inhibitor clade E member 1 (plas
activator inhibitor 1), inhibits ﬁbrinolysis.
Sod2 Sod2: superoxide dismutase 2, a mitochondrial enzyme that converts sup
to hydrogen peroxide, acts in oxidative stress response and may affect ag
Stat3 Stat3: signal transducer activator transcription 3, regulates transcription i
to cytokine and growth factor signals mediated via JAK kinase, acts in cell
and apoptosis; human STAT3 is a marker for RA.
Tgm2 Tgm2: tissue transglutaminase, crosslinks cellular proteins, modulates the
cell adhesion, angiogenesis, skeletal development and apoptosis.
Tnfrsf11b Tnfrsf11b: osteoprotegerin, a soluble member of the tumor necrosis facto
superfamily; inhibits osteoclastogenesis and increases bone density.
Wisp2 Wisp2: Wnt1 inducible signaling pathway protein 2, a member of the CCN
family of growth factors.Comparative pathway analysis
In order to interpret the large number of DE genes, we applied
pathway analysis to our 475 DE genes. The pathway analysis
identiﬁes biological processes signiﬁcantly enriched with DE genes.
The top biological processes identiﬁed in theMTmodel are listed in
Table V. Similarly, we applied the same pathway analysis to the DE
genes obtained from the ACLTmodel12 and human OA array work11.
These identiﬁed biological processes were then compared with
those identiﬁed in the MT model. Table VI shows common bio-
logical processes implicated in cartilage degeneration. Thus, when
compared at the level of biological processes, the two rat models
recapitulatedmany key pathological features of the disease. Figures
4e6 show fold changes observed in the MT and ACLT models and
OA cartilage of individual genes changed in three selected path-
ways: i.e., ECM, programmed cell death, and angiogenesis.
Discussion
Recent pharmaceutical development for OA has focused on
identifying mechanisms that drive the progression of degenerative
lesions in cartilage. An understanding of degenerative mechanisms
is expected to lead to development of disease modifying OA drugs.3 days 7 days 21 days # of papers
pe 1 motif 4, 1.0 1.7 1.6 25
ng 1.5 1.1 1.2 35
h factor beta (TGFb) family of growth 1.8 1.1 1.2 5
protein-39,
ontains a
2.4 2.9 2.8 6
1.5 1.0 1.1 6
1.1 1.5 1.6 2
ll 1), a cell 1.5 1.0 1.1 31
d in 3.2 1.5 1.5 4
inase,
rigger
2.0 1.3 1.1 62
A (Mmp2), 1.3 1.7 1.6 7
alloprotease 1.5 1.2 1.9 173
nﬂammatory 3.6 1.8 1.8 433
1.7 3.0 2.7 30
minogen 2.8 2.4 2.9 27
eroxide
ing.
2.1 1.5 1.5 3
n response
proliferation
1.1 1.2 1.5 4
ECM, 1.7 1.4 1.1 2
r receptor 1.5 1.1 1.1 24
1.6 1.9 2.2 2
Table IV
DE genes in articular cartilage common to human OA and rat models
Gene Description Fold change
MT ACLT OA
3 days 7 days 21 days
AQP1 Aquaporin 1 3.72 4.68
COL3A1 Collagen, type III, alpha 1 1.50 1.59 7.37
COL4A1 Collagen, type IV, alpha 1 2.85 2.6
COL5A1 Collagen, type V, alpha 1 1.62 1.68 5.81
COL6A2 Collagen, type VI, alpha 2 1.70 1.70 1.70 2.96
INHBA Inhibin, beta A 3.19 1.54 1.47 6.13 3.42
LTBP2 Latent transforming growth
factor beta binding protein 2
2.29 2.33 1.93
LUM Lumican 1.73 1.92
MMP3 Matrix metallopeptidase 3 1.45 1.94 3.45
MPST Mercaptopyruvate
sulfurtransferase
1.69 1.72
NBL1 Neuroblastoma, suppression
of tumorigenicity 1
1.70 1.50 1.64 3.57 5.72
NDRG2 NDRG family member 2 2.38 1.75
NR1D1 Nuclear receptor subfamily 1,
group D, member 1
2.90 1.85
PCOLCE Procollagen C-endopeptidase
enhancer
1.66 3.25
RND3 Rho family GTPase 3 1.97 2.11
SERPINA1 Serpin peptidase inhibitor,
clade A, member 1
1.71 2.96 2.71 6.80 1.52
SERPINE1 Serpin peptidase inhibitor,
clade E, member 1
2.84 2.40 2.90 2.38
TIMP1 TIMP metallopeptidase
inhibitor 1
1.91 2.05
TIMP3 TIMP metallopeptidase
inhibitor 3
1.89 1.55 1.96
TUBB2B Tubulin, beta 2B 1.90 2.04
Genes in bold indicates six genes concordantly changed in MT, ACLT and human OA
cartilage.
Fig. 3. Conﬁrmation of up-regulation of Col5a1 and Col6a2 expression in the MT
model by real-time PCR. Conﬁrmation at 1-day time point was not performed due to
shortage of RNA. Primers Rn01435869_m1 for Col5a1 and Rn01429506_m1 for Col6a1
were purchased from Applied Biosystems as Assays on Demand reagents (Foster City,
CA). Speciﬁc ampliﬁcation reactions from the cDNAs were carried out by 2-step real-
time PCR and the relative quantities were obtained by generating a standard curve for
each gene. The expression levels of genes were normalized to 18S ribosomal RNA used
as internal control. All measurements were performed on triplicate samples. Results of
real-time PCR were analyzed by Student’s t test and probability (P) values <0.05 were
considered statistically signiﬁcant. Error bars represent the 95% conﬁdence intervals.
Table V
Biological processes enriched with DE genes identiﬁed in MT model
GO term Gene # P-value
Extracellular region part 105 8.07E17
ECM 26 4.90E09
Cell differentiation 75 2.75E08
Blood vessel development 17 9.14E06
Lipid metabolic 33 9.35E05
Sterol biosynthetic 7 9.43E05
Steroid biosynthetic 10 1.01E04
Cell motility 24 1.03E04
Cell proliferation 34 6.22E04
Bone remodeling 12 0.001778
Cell projection 22 0.002691
Apoptosis 28 0.010204
Neuron projection 12 0.035375
Inﬂammatory response 14 0.039718
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example, focal cartilage degeneration could be seen over the load
bearing surface at 1- and 2-week post-surgery and severe cartilage
degeneration with a deﬁnite osteophyte and periosteal prolifera-
tion at 3-week post-surgery7 Thus, it has been used extensively as
a convenient model to proﬁle compounds for disease modifying
activity8,22. However, it is unclear whether the rapid cartilage
degeneration in this rat model mimics the gradual pathological loss
of cartilage that occurs in the progression of human OA. If it does,
what are potential molecular pathways that drive the early devel-
opment of pathology? To address the two questions, we carried out
the present study in which transcriptome of articular cartilage of
the rat MT model was proﬁled at 7- and 21-day post-surgery at
which histopathologies were readily observed7. To obtain the
earliest molecular clues that potentially drive pathogenesis, we also
proﬁled transcriptome of the rat MTmodel at 3-day post-surgery at
which no histological lesion could be observed.
We identiﬁed 475 DE genes in the MT model at multiple time
points after disease induction. Eleven genes were commonly
changed throughout disease induction (Table I), four of which (Lbp,
Serpine1, Ccl2 and Ptgs2) are wound and inﬂammatory responsiveTable VI
Common biological processes enriched with DE genes
Term Gene # P-value
MT ACLT OA MT ACLT OA
Extracellular space 96 116 20 0.00000 0.00000 0.00001
Proteinaceous ECM 26 36 35 0.00000 0.00000 0.00000
Organ development 66 94 35 0.00000 0.00000 0.00015
Cell development 59 81 28 0.00000 0.00000 0.01241
Blood vessel morphogenesis 16 26 7 0.00001 0.00000 0.02779
Vasculature development 17 31 8 0.00001 0.00000 0.01706
Angiogenesis 13 19 7 0.00007 0.00000 0.01445
Skeletal development 18 22 14 0.00012 0.00013 0.00002
Negative regulation of cellular
process
43 67 29 0.00014 0.00000 0.00180
Tissue development 22 26 11 0.00023 0.00080 0.01948
Collagen 7 8 11 0.00026 0.00021 0.00000
Anatomical structure formation 13 20 7 0.00062 0.00000 0.03789
Cytoplasm 129 169 115 0.00122 0.00222 0.00000
Fibrillar collagen 4 3 7 0.00187 0.04779 0.00000
Biomineral formation 11 13 5 0.00201 0.00285 0.04684
Ossiﬁcation 11 13 5 0.00201 0.00285 0.04684
Programmed cell death 26 44 18 0.01346 0.00009 0.04690
Anion transport 11 13 13 0.01420 0.02430 0.00002
Regulation of cell growth 8 19 7 0.02694 0.00000 0.02009
Cell growth 9 22 8 0.03522 0.00000 0.01738
Fig. 4. Up-regulated ECM genes in the articular cartilage of the rat OA models and human OA. MT, meniscus tear; ACLT, anterior cruciate ligament transection; OA, osteoarthritis.
Fold changes are calculated as the average expression abundance of a treatment group divided by that of its control group.
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time points in the present study (Fig. 1) suggests signiﬁcant time-
dependent changes occur as pathology develops in the rat MT
model.
We also identiﬁed 649 DE genes by analyzing a public array
dataset generated from the rat ACLT model12. There are only 61
genes common to the MT and ACLT models. Obviously, some of the
differences were due to the fact that the ACLT model was studied at
4 weeks after disease induction. Indeed, there was increasing
percentage of DE genes common to the MT and ACLT models
(Fig. 2). For example, compared with only 10% overlapping of DE
genes between 3-day MT model and 4-week ACLT model, much
higher overlapping of DE genes was observed between 4-week
ACLT and 7-day MT (29%) and 21-day MT (38%).
COL2A1, COL10A1, ADAMTS5 and MMP13 are known to play
important roles in cartilage integrity and OA pathogenesis.
However, except for MMP13 which increased expression in the
ACLT model, the other three genes were not altered in either
model. Our analysis of Affymetrix probe design suggests that
faulty probe design for the three genes accounts for the apparent
discrepancies (Supplementary Fig. 1). MMP13 is well represented
by probe set 1388204_at. While it is abundant in the rat articular
cartilage, its expression was not changed in the MT model at time
points up to 3-week post-surgery. The expression of MMP13 was
up-regulated over two-fold in the 4-week ACLT cartilage. The
difference suggests that the increase of MMP13 expression may
occur later in the development of pathology in the rat OA
models.
To systematically evaluate if the rat MT model mimics human
OA pathology, we ﬁrst compared the DE genes from the rat MT
model with a list of OA-related genes reported in the literature.
As shown in Table III, 19 out of the 175 OA-related genes
reported in the literature were identiﬁed in the MT model. A
similar low overlap between human OA-related genes and DE
genes was noticed in the monosodium iodoacetate-induced ratOA model23. Many factors can contribute to poor overlap of DE
genes between human OA and OA animal models. For example,
human OA is a disease with great heterogeneity thus experi-
mental animal models that are more kinetically in-phase might
only mimic some aspects of human disease. In addition, the rat
models proﬁled both here and previously by Appleton et al.12
may be more accurately described as models of acute joint
injury. A more relevant comparison may be to compare the
expression changes in the rat models with the expression
changes in human cartilage after an acute joint injury e.g., ACLT
rupture or meniscal injury.
We also compared DE genes identiﬁed in the MT and ACLT
models with human OA-related genes identiﬁed by a recent global
expression proﬁling of cartilage11. As shown in Table IV, there are 20
genes commonly changed in the rat OA models and in human OA
cartilage. Part of the reason for the large difference could be due to
the fact that Aigner et al. focused on the later stages of cartilage
pathology. In contrast, our present study focused on identifying
early molecular events by proﬁling the cartilage transcriptome in
the MTmodel. Six of the 20 genes were changed in both rat models
and human OA cartilage. In particular, INHBA and NBL1 are involved
in transforming growth factor beta (TGFb) and bonemorphogenetic
protein (BMP) signaling pathways, known to play signiﬁcant roles
for cartilage homeostasis. Since INHBA was shown to inhibit
aggrecanase-mediated cleavage of aggrecan in human and rat
articular cartilage, its increased expression may represent
a common protective mechanism that is intact in the diseased
cartilage. Bone morphogenetic proteins are known anabolic factors
with activity of cartilage repair24. By integrated data analysis, we
also identiﬁed NBL1, a secreted BMP antagonist that increased its
expression in human OA cartilage and the two rat OAmodels. These
data suggest that attenuation of cartilage anabolism by increasing
expression of the antagonist of BMP signaling may be one of the
possible molecular mechanisms of cartilage degeneration common
to both human OA and the rat OA models and thus neutralizing
Fig. 5. DE genes related to programmed cell death deﬁned in Gene Ontology (GO) database. MT, meniscus tear; ACLT, anterior cruciate ligament transection; OA, osteoarthritis. Fold
changes are calculated as the average expression abundance of a treatment group divided by that of its control group.
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cartilage.
Although there is a small overall overlap of DE genes identiﬁed
from human OA cartilage and the rat OA models, our pathway
analysis revealed several key pathologically relevant pathways that
were similarly dysregulated in both rat MT and ACLT models and
human disease (Table VI). Figure 4 shows a consistent up-regula-
tion of ECM genes in MT, ACLT and human OA cartilage, suggesting
a higher ECM turnover in degenerative cartilage in spite of the fact
that many genes in this functional group were different in three
studies.
Chondrocyte apoptosis is one of well-established cellular
mechanisms for cartilage degeneration. CASP10, which plays a key
role in activating caspase-mediated apoptosis, increased >two-fold
in human OA cartilage (Fig. 5). On the other hand, Bcl2, an impor-
tant anti-apoptosis gene, was down-regulated in ACLT model.
Consistent with increased chondrocyte apoptosis, increased
expression of Tgm2, a characteristic of cells undergoing apoptosis25,
was observed in both MT and ACLT models.
Furthermore, we observed inﬂammation related genes were
signiﬁcantly up-regulated in both MT and ACLT cartilage
(Supplemental Fig. 2). Increased expression was readily observed
as early as 3-day post-MT and persistent to 3-week (MT) and
4-week (ACLT) post-surgery. Although not detected by Aigner’s
study, inﬂammation is believed to be an important component of
OA26. Obesity is a key risk factor of OA. It is not clear, however, ifit is simply due to mechanical overloading or metabolism related
or both. Sterol biosynthesis was among the most signiﬁcant
pathways that was consistently up-regulated in the 3-day MT
cartilage (Table V, Supplemental Fig. 3). Increased serum
cholesterol was observed in the STR/ort mouse, a model of
murine spontaneous OA27. In addition, recent work revealed
impaired expression of genes regulating cholesterol efﬂux in
human osteoarthritic chondrocytes28. Simopoulou et al. demon-
strated that treatment of human OA chondrocytes with an HMG-
CoA reductase inhibitor resulted in beneﬁcial changes in the
expression of genes related to both cartilage anabolism and
cartilage catabolism29. Statin beneﬁcial effects on cartilage have
also been demonstrated previously in an in vivo OA model30.
While this may be due to its anti-inﬂammation effect, the statin
could also promote chondrogenesis by directly inhibiting
cholesterol biosynthesis pathway as recently demonstrated31,32.
In summary, we identiﬁed a large number of DE genes in the
articular cartilage of theMTmodel. While there was a small overlap
of DE genes between human OA cartilage and cartilage from the rat
MT and ACLT models, our pathway analysis revealed the animal
models recapitulated several key biological processes, namely
increased ECM remodeling, angiogenesis and chondrocyte
apoptosis, associated with human OA pathogenesis. Furthermore,
pathway analysis of the rat models suggested increased inﬂam-
mation and cholesterol metabolism may play important role in
early cartilage degeneration.
Fig. 6. DE genes related to angiogenesis as deﬁned in Gene Ontology (GO) database. MT, meniscus tear; ACLT, anterior cruciate ligament transection; OA, osteoarthritis. Fold change
is calculated as the average expression abundance of a treatment group divided by that of its control group.
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